Democratic Republic of Congo vs India: Average cost of drugs for extensively drug-resistant tuberculosis
Democratic Republic of Congo
1,102 constant 2022 US$
in 2024
India
1,203 constant 2022 US$
in 2024
Democratic Republic of Congo rank
41st
India rank
39th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Democratic Republic of Congo
- India
How they compare
India currently reports 1,203 constant 2022 US$ against 1,102 constant 2022 US$ in Democratic Republic of Congo, a difference of 101 constant 2022 US$.
That makes India's figure about 1.1 times Democratic Republic of Congo's.
The two have swapped places 4 times across 8 shared years of data; in 2017 it was India ahead.
Democratic Republic of Congo ranks 41st and India ranks 39th of 56 countries.
Across the 2 decades both report, Democratic Republic of Congo averaged higher in 1 and India in 1.
Head to head by decade
| Decade | Democratic Republic of Congo | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,113 constant 2022 US$ | 7,000 constant 2022 US$ | 886.67 constant 2022 US$ | India |
| 2020s | 2,939 constant 2022 US$ | 2,104 constant 2022 US$ | 835.6 constant 2022 US$ | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Democratic Republic of Congo or India?
- India, at 1,203 constant 2022 US$ against 1,102 constant 2022 US$ in Democratic Republic of Congo as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Democratic Republic of Congo and India?
- 101 constant 2022 US$, with India ahead.
- How many years of comparable data are there for Democratic Republic of Congo and India?
- 8 years are reported by both, from 2017 to 2024.
- How do Democratic Republic of Congo and India rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Democratic Republic of Congo ranks 41st and India ranks 39th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.